TP53 and breast carcinoma: For example, p53 is subjected to phosphorylation, ubiquitination, and SUMOylation in addition to acetylation, which collectively regulate its stability and transcriptional activity [98]; lovastatin, a potential candidate for breast cancer intervention, activates p53 via inducing both S15 phosphorylation and K379 acetylation [99].